共 50 条
- [3] Outcomes of patients with childhood B-cell precursor acute lymphoblastic leukaemia with late bone marrow relapses: long-term follow-up of the ALLR3 open-label randomised trial LANCET HAEMATOLOGY, 2019, 6 (04): : E204 - E216
- [8] Bone marrow necrosis and hyperinflammation after treatment with inotuzumab ozogamicin for B-cell acute lymphoblastic leukaemia LANCET, 2024, 404 (10459): : 1253 - 1254